http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578448-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_798a312a7ed8046ac770bd9ee642378b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 |
| filingDate | 2015-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4134e5e6f87e4fdc7abb573c0084d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd99cca7263ea1a0309a4efd814ee721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be6ad35979c41cd5a2f86ee917f5915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cba08530f37f51700d5c49f76434371 |
| publicationDate | 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2578448-C1 |
| titleOfInvention | Method for diagnosing festering postnecrotic pancreatic pseudocysts |
| abstract | FIELD: medicine. n SUBSTANCE: invention can be used to diagnose festering postnecrotic pancreatic pseudocyst. To do this, a patient's blood phagocytic activity was determined by the level of expression of CD 14 + /HLA-DR + Flow cytometry and statistical ROC-analysis. When the content of CD14 + / HLA-DR + below 85% are diagnosed with festering postnecrotic pancreatic pseudocysts. n EFFECT: use this method to diagnose festering postnecrotic pancreatic pseudocysts that allows you to define the tactics of such patients, and choices of surgery. n 1 cl, 2 ex, 1 tbl |
| priorityDate | 2015-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.